Carvykti

(ciltacabtagene autoleucel)
CARVYKTI 100,000,000 CELLS in 30 ML InjectionCARVYKTI 100,000,000 CELLS in 70 ML Injection

Dosage & administration

For autologous use only. For intravenous use only.

biomarker testing

Carvykti clinical details

Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.

drug label

Carvykti prescribing information

prior authorization

Carvykti prior authorization resources

OTHER
Complete Letter of Medical Necessity

PDF
Prior Authorization Checklist

OTHER
Coverage Authorization Appeal
Learn More

patient education

Carvykti patient education

Getting started on Carvykti

To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

PDF
Patient Brochure
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Patient Wallet Card
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

BRAND PAGE
About Carvykti
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
Receiving Carvykti
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

VIDEO
Patient Stories
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
Patient Resources
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Monitoring For Side Effects Brochure
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Patient Milestone Guidebook
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

Other resources

Learn More

people also ask

Carvykti FAQs

How is the dosage of Carvykti?Carvykti is available in 2 dosages, including 1,430,000 cells/ml Injection 70 ml and 3,330,000 cells/ml Injection 30 ml
What does Carvykti treat?Carvykti treats Multiple Myeloma
How Is Carvykti Administered?Carvykti is administered as a Injectable
FAQ Data Source